Metavention
Eden Prairie, US · Founded 2012 · 5 employees on LinkedIn · 4 known investors
Find your way into Metavention
Sign up to see every warm intro you have to Metavention
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Metavention team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases. The company works on a medical intervention for hypertension and related metabolic conditions.
Founders & leadership

Investors · 4
How we know: Sanderling Ventures's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2017
▶$30MraisedDec 2017 · 11 investors · OtherRule 506(b)
- Bobak AzamianExecutive Officer, Director
- Tony VrbaExecutive Officer
- Kevin HykesExecutive Officer, Director
- Kirk NielsenDirector
- Offering amount
- $65.4M
- Amount sold
- $30M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Metavention went on to found or lead other companies.
Frequently asked questions
- What does Metavention do?
- Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases. The company works on a medical intervention for hypertension and related metabolic conditions.
- Who are Metavention's investors?
- Metavention's investors include Sanderling Ventures, New Enterprise Associates (NEA), Vensana Capital, Versant Ventures.
- How much funding has Metavention raised?
- Metavention has disclosed $30M raised across 1 round.
- Where is Metavention headquartered?
- Metavention is headquartered in Eden Prairie, US.




